SRS MapCHECK半导体矩阵用于射波刀脊柱计划剂量验证的应用研究

目的:评估SRS MapCHECK半导体矩阵探测器用于射波刀脊柱计划剂量验证工作的适用性。方法:将SRS MapCHECK探测器安装于专用模体StereoPHAN开展研究工作,测试了射波刀固定和Iris可变准直器的单野计划,以及脊柱临床计划的质量保证（QA）计划,采用SNC Patient软件对比分析实测与计划剂量分布之间的差异,分别计算在2 mm/5%、2 mm/3%和2 mm/2%标准下的γ通过率。结果:在绝对剂量分析模式2 mm/5%,2 mm/3%和2 mm/2%标准下,固定和Iris可变准直器单野计划的γ通过率均为100.0%,脊柱QA计划的平均γ通过率分别为（99.3±1.2）%、（96.5±2.7）%和（93.5±5.3）%。结论:SRS MapCHECK半导体矩阵探测器在2 mm/5%和2 mm/3%的γ分析标准下适合用于开展射波刀脊柱临床计划的剂量验证工作。     

Use of a two-dimensional ionization chamber array for proton therapy beam quality assurance

Two-dimensional ion chamber arrays are primarily used for conventional and intensity modulated radiotherapy quality assurance. There is no commercial device of such type available on the market that is offered for proton therapy quality assurance. We have investigated suitability of the MatriXX, a commercial two-dimensional ion chamber array detector for proton therapy QA. This device is designed to be used for photon and electron therapy QA. The device is equipped with 32 x 32 parallel plate ion chambers, each with 4.5 mm diam and 7.62 mm center-to-center separation. A 250 MeV proton beam was used to calibrate the dose measured by this device. The water equivalent thickness of the buildup material was determined to be 3.9 mm using a 160 MeV proton beam. Proton beams of different energies were used to measure the reproducibility of dose output and to evaluate the consistency in the beam flatness and symmetry measured by MatriXX. The output measurement results were compared with the clinical commissioning beam data that were obtained using a 0.6 cc Farmer chamber. The agreement was consistently found to be within 1%. The profiles were compared with film dosimetry and also with ion chamber data in water with an excellent agreement. The device is found to be well suited for quality assurance of proton therapy beams. It provides fast two-dimensional dose distribution information in real time with the accuracy comparable to that of ion chamber measurements and film dosimetry.     

A practical Monte Carlo MU verification tool for IMRT quality assurance

Quality assurance (QA) for intensity-modulated radiation therapy (IMRT) treatment planning and beam delivery, using ionization chamber measurements and film dosimetry in a phantom, is time consuming. The Monte Carlo method is the most accurate method for radiotherapy dose calculation. However, a major drawback of Monte Carlo dose calculation as currently implemented is its slow speed. The goal of this work is to bring the efficiency of Monte Carlo into a practical range by developing a fast Monte Carlo monitor unit (MU) verification tool for IMRT. A special estimator for dose at a point called the point detector has been used in this research. The point detector uses the next event estimation (NEE) method to calculate the photon energy fluence at a point of interest and then converts it to collision kerma by the mass energy absorption coefficient assuming the presence of transient charged particle equilibrium. The MU verification tool has been validated by comparing the calculation results with measurements. It can be used for both patient dose verification and phantom QA calculation. The dynamic leaf-sequence log file is used to rebuild the actual MLC leaf sequence in order to predict the dose actually received by the patient. Dose calculations for 20 patient plans have been performed using the point detector method. Results were compared with direct Monte Carlo simulations using EGS4/MCSIM, which is a well-benchmarked Monte Carlo code. The results between the point detector and MCSIM agreed to within 2%. A factor of 20 speedup can be achieved with the point detector method compared with direct Monte Carlo simulations.     

Comparison of Dosimetric Performance among Commercial Quality Assurance Systems for Verifying Pretreatment Plans of Stereotactic Body Radiotherapy Using Flattening-Filter-Free Beams

The purpose of this study was to compare the performance of different commercial quality assurance (QA) systems for the pretreatment verification plan of stereotactic body radiotherapy (SBRT) with volumetric arc therapy (VMAT) technique using a flattening-filter-free beam. The verification for 20 pretreatment cancer patients (seven lung, six spine, and seven prostate cancers) were tested using three QA systems (EBT3 film, I’mRT MatriXX array, and MapCHECK). All the SBRT-VMAT plans were optimized in the Eclipse (version 11.0.34) treatment planning system (TPS) using the Acuros XB dose calculation algorithm and were delivered to the Varian TrueBeam^® accelerator equipped with a high-definition multileaf collimator. Gamma agreement evaluation was analyzed with the criteria of 2% dose difference and 2 mm distance to agreement (2%/2 mm) or 3%/3 mm. The highest passing rate (99.1% for 3%/3 mm) was observed on the MapCHECK system while the lowest passing rate was obtained on the film. The pretreatment verification results depend on the QA systems, treatment sites, and delivery beam energies. However, the delivery QA results for all QA systems based on the TPS calculation showed a good agreement of more than 90% for both the criteria. It is concluded that the three 2D QA systems have sufficient potential for pretreatment verification of the SBRT-VMAT plan.     

Analysis of various beamlet sizes for IMRT with 6 MV photons

Application of intensity modulated radiation therapy (IMRT) using multileaf collimation often requires the use of small beamlets to optimize the delivered radiation distribution. Small-beam dose distribution measurements were compared to dose distributions calculated using a commercial treatment planning system that models its data acquired using measurements from relatively large fields. We wanted to evaluate only the penumbra, percent depth-dose (PDD) and output model, so we avoided dose distribution features caused by rounded leaf ends and interleaf leakage by making measurements using the secondary collimators. We used a validated radiochromic film dosimetry system to measure high-resolution dose distributions of 6 MV photon beams. A commercial treatment planning system using the finite size pencil beam (FSPB) dose calculation algorithm was commissioned using measured central axis outputs from 4.0x4.0 to 40.0x40.0 cm2 beams and radiographic-film profile measurements of a 4.0x4.0 cm2 beam at twice the depth of maximum dose (dmax). Calculated dose distributions for square fields of 0.5x0.5 cm2, and 1.0x1.0 cm2, to 6.0x6.0 cm2, in 1.0x1.0 cm2, increments were compared against radiochromic film measurements taken with the film oriented parallel to the beam central axis in a water equivalent phantom. The PDD of the smaller field sizes exhibited behavior typical of small fields, namely a decrease in dmax with decreasing field size. The FSPB accurately modeled the depth-dose and central axis output for depths deeper than the nominal dmax of 1.5 cm plus 0.5 cm. The dose distribution in the build-up and penumbra regions was not accurately modeled for depths less than 2 cm, especially for the fields of 2.0x2.0 cm2 and smaller. Using the gamma function with 2 mm and 2% criteria, the dose model was shown to accurately predict the penumbra. While for single small beams the compared dose distributions passed the gamma function criteria, the clinical appropriateness of these criteria is not clear for a composite IMRT plan. Further investigation of the cumulative impact of the observed dose discrepancies is warranted. We speculate that the observed differences in the penumbra regions arise from some energy dependent artifact in the radiographic-film profiles used for commissioning. In the future, radiochromic film based commissioning might provide a more accurate data set for dose modeling.     

An analysis of tolerance levels in IMRT quality assurance procedures

Increased use of intensity modulated radiation therapy (IMRT) has resulted in increased efforts in patient quality assurance (QA). Software and detector systems intended to streamline the IMRT quality assurance process often report metrics, such as percent discrepancies between measured and computed doses, which can be compared to benchmark or threshold values. The purpose of this work is to examine the relationships between two different types of IMRT QA processes in order to define, or refine, appropriate tolerances values. For 115 IMRT plans delivered in a 3 month period, we examine the discrepancies between (a) the treatment planning system (TPS) and results from a commercial independent monitor unit (MU) calculation program; (b) TPS and results from a commercial diode-array measurement system; and (c) the independent MU calculation and the diode-array measurements. Statistical tests were performed to assess significance in the IMRT QA results for different disease site and machine models. There is no evidence that the average total dose discrepancy in the monitor unit calculation depends on the disease site. Second, the discrepancies in the two IMRT QA methods are independent: there is no evidence that a better--or worse--monitor unit validation result is related to a better--or worse--diode-array measurement result. Third, there is marginal benefit in repeating the independent MU calculation with a more suitable dose point, if the initial IMRT QA failed a certain tolerance. Based on these findings, the authors conclude at some acceptable tolerances based on disease site and IMRT QA method. Specifically, monitor unit validations are expected to have a total dose discrepancy of 3% overall, and 5% per beam, independent of disease site. Diode array measurements are expected to have a total absolute dose discrepancy of 3% overall, and 3% per beam, independent of disease site. The percent of pixels exceeding a 3% and 3 mm threshold in a gamma analysis should be greater than or equal to 95% for non-head and neck IMRT cases, and 88% for head and neck IMRT cases. The IMRT QA methodology described here is neither unique nor ubiquitous, and the ability to deliver a safe IMRT does not simply require IMRT QA tests to pass a given tolerance; however, the selection of a tolerance should be meaningful when assessing a complex plan. The methodology in defining appropriate tolerances, described in this article, is based on an interpretation of IMRT QA results from IMRT plans deemed safe to deliver.     

基于EPID采用参数化梯度法测定光子束射野边界

【摘 要】 目的:探究参数化梯度方法（PGM）测量电子射野影像系统（EPID）光子束射野大小的可行性。 方法:PGM通过一个修改的双曲正切函数拟合Profile半影区。瓦里安EDGE机载aS1200采集6 MV和10 MV FF及FFF射束EPID数据,TrueBeam机载aS1000采集6 MV FF射束EPID数据。γ分析1 mm/1%标准量化PGM拟合Profile半影区与EPID测量半影区一致性。比较半高宽方法与PGM测量的FF射束射野大小,比较最大斜率方法与PGM测量的FFF射束射野大小;比较PGM在不同射束能量、不同EPID探测器类型和引入铅门位置误差后测量射野边界的稳定性和扩展性。 结果:半影区PGM拟合与EPID实测数据Pearson相关系数大于0.999,γ值小于0.2。FF射束,半高宽方法测定射野均大于PGM,且随着射野增大而增大,Profile本影去除后,两种方法测量差值显著减小;FFF射束,最大斜率方法与PGM测定射野大小差值在0.1 mm以内。PGM能够稳定测量不同能量、不同模态、不同EPID探测器类型射野边界,能够准确识别铅门1 mm位置变动。 结论:PGM可作为一种鲁棒通用的方法适用于EPID光子束射野质量保障。     

Compton-scattering measurement of diagnostic x-ray spectrum using high-resolution Schottky CdTe detector

The analysis of x-ray spectra is important for quality assurance (QA) and quality control (QC) of radiographic systems. The aim of this study is to measure the diagnostic x-ray spectra under clinical conditions using a high-resolution Schottky CdTe detector. Under clinical conditions, the direct measurement of a diagnostic spectrum is difficult because of the high photon fluence rates that cause significant detector photon pile-up. An alternative way of measuring the output spectra from a tube is first to measure the 90 deg Compton scattered photons from a given sample. With this set-up detector, pile-up is not a problem. From the scattered spectrum one can then use an energy correction and the Klein-Nishina function to reconstruct the actual spectrum incident upon the scattering sample. The verification of whether our spectra measured by the Compton method are accurate was accomplished by comparing exposure rates calculated from the reconstructed spectra to those measured with an ionization chamber. We used aluminum (Al) filtration ranging in thickness from 0 to 6 mm. The half value layers (HVLs) obtained for a 70 kV beam were 2.78 mm via the ionization chamber measurements and 2.93 mm via the spectral measurements. For a 100 kV beam we obtained 3.98 and 4.32 mm. The small differences in HVLs obtained by both techniques suggest that Compton scatter spectroscopy with a Schottky CdTe detector is suitable for measuring the diagnostic x-ray spectra and useful for QA and QC of clinical x-ray equipment.     

Slit x-ray beam primary dose profiles determined by analytical transport of Compton recoil electrons

Accurate measurement of radiation beam penumbras is essential for conformal radiotherapy. For this purpose a detailed knowledge of the dosimeter's spatial response is required. However, experimental determination of detector spatial response is cumbersome and restricted to the specific detector type and beam spectrum used. A model has therefore been developed to calculate in slit beam geometry both dose profiles and detector response profiles. Summations over representative photon beam spectra yield profiles for polyenergetic beams. In the present study the model is described and resulting dose profiles verified. The model combines Compton scattering of incident photons, transport of resulting electrons by Fermi-Eyges small-angle multiple scattering theory, and functions to limit electron transport. This analytic model thus yields line spread kernels of primary dose in a water phantom. It is shown that the spatial response of an ideal point detector to a primary photon beam can be well described by the model; the calculations are verified by measurements with a diamond detector in a telescopic slit geometry in which all dose contributions except for the primary dose can be excluded. Effects of photon detector behavior, source size of the linear accelerator (linac) and detector size are studied. Measurements show that slit dose profiles calculated by means of the kernel are accurate within 0.1 mm of the full-width at half-maximum. For a theoretical point source and point detector combined with a 0.2 mm wide slit, the full-width half-maximum values of the slit beam dose profiles are calculated as 0.37 mm and 0.42 mm in a 6 MV and 25 MV x-ray beam, respectively. The present study shows that the model is adequate to calculate local dose effects that are dominated by approximately mono-directional, primary photon fluence. The analytic model further provides directional electron fluence information and is designed to be applied to various detectors and linac beam spectra.     

Dosimetric considerations for validation of a sequential IMRT process with a commercial treatment planning system

Commercial multileaf collimator (MLC) systems can employ leaves with rounded ends. Treatment planning beam modelling should consider the effects of transmission through rounded leaf ends to provide accurate dosimetry for IMRT treatments delivered with segmented MLC. We determined that an MLC leaf gap reduction of 1.4 mm is required to obtain an agreement between calculated and measured profile 50% dose points. A head and neck dosimetry phantom, supplied by the Radiological Physics Center (RPC), was planned and irradiated as a necessary credentialing requirement for the RTOG H-0022 protocol. The agreement between the RPC TLD measurements and treatment planning calculations was within experimental error for the primary and secondary planning target volumes (PTVs); however, the calculated mean dose for the critical structure was approximately 9% lower than the RPC TLD measurements. RPC radiochromic film profile measurements also indicated significant discrepancies (>5%) with calculated values especially in the high dose gradient region in the vicinity of the critical structure. These results substantiate our own in-house phantom measurements, performed with the same IMRT fields as for the RPC phantom experiment, using Kodak EDR2 film to measure absolute dose. Our results indicate a maximum underestimate of calculated dose of 12% with no leaf gap reduction. The discrepancy between measured and calculated phantom values is reduced to +/- 5% when a leaf gap reduction of 1.4 mm is used. A further improvement in the accuracy of dose calculation is not possible without a more accurate modelling of the leaf end transmission by the planning system. In the absence of published dosimetric criteria for IMRT our results stress the need for stringent in-house dosimetric QA and validation for IMRT treatments. We found the dosimetric validation service provided by the RPC to be a valuable component of our IMRT validation efforts.     

SunCHECK软件在调强放疗计划剂量验证中的应用

目的:探讨SunCHECK软件在调强放疗计划剂量验证中的应用。方法:选取新疆医科大学第一附属医院已执行IMRT计划的40例患者,应用SunCHECK软件,对所接受数据进行单独计算,然后对原始放疗计划和QA计划进行Gamma分析。最后对QA计划与ArcCHECK测量结果进行Gamma通过率比较。结果:在SunCHECK软件单独计算结果中,Monaco计划平均Gamma通过率略高于Eclipse计划。相同计划系统原始计划与QA计划Gamma通过率没有差异。使用SunCHECK软件计算QA计划（包括Monaco计划和Eclipse计划）Gamma通过率略高于ArcCHECK测量结果的Gamma通过率。结论:SunCHECK软件符合IMRT计划剂量验证需要,给放疗质控工作带来了很大的便利性。无论是作为单独放疗计划验算工具,还是以log日志文件反推进行计划验证,都应该把SunCHECK作为质量保证程序的一部分。     

The use of film dosimetry of the penumbra region to improve the accuracy of intensity modulated radiotherapy

Accurate measurements of the penumbra region are important for the proper modeling of the radiation beam for linear accelerator-based intensity modulated radiation therapy. The usual data collection technique with a standard ionization chamber artificially broadens the measured beam penumbrae due to volume effects. The larger the chamber, the greater is the spurious increase in penumbra width. This leads to inaccuracies in dose calculations of small fields, including small fields or beam segments used in IMRT. This source of error can be rectified by the use of film dosimetry for penumbra measurements because of its high spatial resolution. The accuracy of IMRT calculations with a pencil beam convolution model in a commercial treatment planning system was examined using commissioning data with and without the benefit of film dosimetry of the beam penumbrae. A set of dose-spread kernels of the pencil beam model was calculated based on commissioning data that included beam profiles gathered with a 0.6-cm-i.d. ionization chamber. A second set of dose-spread kernels was calculated using the same commissioning data with the exception of the penumbrae, which were measured with radiographic film. The average decrease in the measured width of the 80%-20% penumbrae of various square fields of size 3-40 cm, at 5 cm depth in water-equivalent plastic was 0.27 cm. Calculations using the pencil beam model after it was re-commissioned using film dosimetry of the penumbrae gave better agreement with measurements of IMRT fields, including superior reproduction of high dose gradient regions and dose extrema. These results show that accurately measuring the beam penumbrae improves the accuracy of the dose distributions predicted by the treatment planning system and thus is important when commissioning beam models used for IMRT.     

A virtual photon source model of an Elekta linear accelerator with integrated mini MLC for Monte Carlo based IMRT dose calculation

A dedicated, efficient Monte Carlo (MC) accelerator head model for intensity modulated stereotactic radiosurgery treatment planning is needed to afford a highly accurate simulation of tiny IMRT fields. A virtual source model (VSM) of a mini multi-leaf collimator (MLC) (the Elekta Beam Modulator (EBM)) is presented, allowing efficient generation of particles even for small fields. The VSM of the EBM is based on a previously published virtual photon energy fluence model (VEF) (Fippel et al 2003 Med. Phys. 30 301) commissioned with large field measurements in air and in water. The original commissioning procedure of the VEF, based on large field measurements only, leads to inaccuracies for small fields. In order to improve the VSM, it was necessary to change the VEF model by developing (1) a method to determine the primary photon source diameter, relevant for output factor calculations, (2) a model of the influence of the flattening filter on the secondary photon spectrum and (3) a more realistic primary photon spectrum. The VSM model is used to generate the source phase space data above the mini-MLC. Later the particles are transmitted through the mini-MLC by a passive filter function which significantly speeds up the time of generation of the phase space data after the mini-MLC, used for calculation of the dose distribution in the patient. The improved VSM model was commissioned for 6 and 15 MV beams. The results of MC simulation are in very good agreement with measurements. Less than 2% of local difference between the MC simulation and the diamond detector measurement of the output factors in water was achieved. The X, Y and Z profiles measured in water with an ion chamber (V = 0.125 cm(3)) and a diamond detector were used to validate the models. An overall agreement of 2%/2 mm for high dose regions and 3%/2 mm in low dose regions between measurement and MC simulation for field sizes from 0.8 x 0.8 cm(2) to 16 x 21 cm(2) was achieved. An IMRT plan film verification was performed for two cases: 6 MV head&neck and 15 MV prostate. The simulation is in agreement with film measurements within 2%/2 mm in the high dose regions (> or = 0.1 Gy = 5% D(max)) and 5%/2 mm in low dose regions (<0.1 Gy).     

An investigation of the accuracy of an IMRT dose distribution using two- and three-dimensional dosimetry techniques

Complex dose delivery techniques like intensity-modulated radiation therapy (IMRT) require dose measurement in three dimensions for comprehensive validation. Previously, we demonstrated the feasibility of the "PRESAGE/optical-computed tomography (CT)" system for the three-dimensional verification of simple open beam dose distributions where the planning system was known to be accurate. The present work extends this effort and presents the first application of the PRESAGE/optical-CT system for the verification of a complex IMRT distribution. A highly modulated 11 field IMRT plan was delivered to a cylindrical PRESAGE dosimeter (16 cm in diameter and 11 cm in height), and the dose distribution was readout using a commercial scanning-laser optical-CT scanner. Comparisons were made with independent GAFCHROMIC EBT film measurements, and the calculated dose distribution from a commissioned treatment planning system (ECLIPSE). Isodose plots, dose profiles, gamma maps, and dose-volume histograms were used to evaluate the agreement. The isodose plots and dose profiles from the PRESAGE/optical-CT system were in excellent agreement with both the EBT measurements and the ECLIPSE calculation at all points except within 3 mm of the outer edge of the dosimeter where an edge artifact occurred. Excluding this 3 mm rim, gamma map comparisons show that all three distributions mutually agreed to within a 3% (dose difference) and 3 mm (distance-to-agreement) criteria. A 96% gamma pass ratio was obtained between the PRESAGE and ECLIPSE distributions over the entire volume excluding this rim. In conclusion, for the complex IMRT plan studied, and in the absence of inhomogeneities, the ECLIPSE dose calculation was found to agree with both independent measurements, to within 3%, 3 mm gamma criteria.     

Dosimetric characterization of CyberKnife radiosurgical photon beams using polymer gels

Dose distributions registered in water equivalent, polymer gel dosimeters were used to measure the output factors and off-axis profiles of the radiosurgical photon beams employed for CyberKnife radiosurgery. Corresponding measurements were also performed using a shielded silicon diode commonly employed for CyberKnife commissioning, the PinPoint ion chamber, and Gafchromic EBT films, for reasons of comparison. Polymer gel results of this work for the output factors of the 5, 7.5, and 10 mm diameter beams are (0.702 +/- 0.029), (0.872 +/- 0.039), and (0.929 +/- 0.041), respectively. Comparison of polymer gel and diode measurements shows that the latter overestimate output factors of the two small beams (5% for the 5 mm beam and 3% for the 7.5 mm beams). This is attributed to the nonwater equivalence of the high atomic number silicon material of the diode detector. On the other hand, the PinPoint chamber is found to underestimate output factors up to 10% for the 5 mm beam due to volume averaging effects. Polymer gel and EBT film output factor results are found in close agreement for all beam sizes, emphasizing the importance of water equivalence and fine detector sensitive volume for small field dosimetry. Relative off-axis profile results are in good agreement for all dosimeters used in this work, with noticeable differences observed only in the PinPoint estimate of the 80%-20% penumbra width, which is relatively overestimated.     

Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the Therapy Physics Committee of the AAPM

For commissioning a linear accelerator for clinical use, medical physicists are faced with many challenges including the need for precision, a variety of testing methods, data validation, the lack of standards, and time constraints. Since commissioning beam data are treated as a reference and ultimately used by treatment planning systems, it is vitally important that the collected data are of the highest quality to avoid dosimetric and patient treatment errors that may subsequently lead to a poor radiation outcome. Beam data commissioning should be performed with appropriate knowledge and proper tools and should be independent of the person collecting the data. To achieve this goal, Task Group 106 (TG-106) of the Therapy Physics Committee of the American Association of Physicists in Medicine was formed to review the practical aspects as well as the physics of linear accelerator commissioning. The report provides guidelines and recommendations on the proper selection of phantoms and detectors, setting up of a phantom for data acquisition (both scanning and no-scanning data), procedures for acquiring specific photon and electron beam parameters and methods to reduce measurement errors (<1%), beam data processing and detector size convolution for accurate profiles. The TG-106 also provides a brief.discussion on the emerging trend in Monte Carlo simulation techniques in photon and electron beam commissioning. The procedures described in this report should assist a qualified medical physicist in either measuring a complete set of beam data, or in verifying a subset of data before initial use or for periodic quality assurance measurements. By combining practical experience with theoretical discussion, this document sets a new standard for beam data commissioning.     

The value of EDR2 film dosimetry in compensator-based intensity modulated radiation therapy

Radiographic or silver halide film is a well-established 2D dosimeter with an unquestioned spatial resolution. But its higher sensitivity to low-energy photons has to be taken into consideration. Metal compensators or physical modulators to deliver intensity modulated radiation therapy (IMRT) are known to change the beam energy spectrum and to produce scattered photons and contaminating electrons. Therefore the reliability of film dosimetry in compensator-based IMRT might be questioned. Conflicting data have been reported in the literature. This uncertainty about the validity of film dosimetry in compensator-based IMRT triggered us to conduct this study. First, the effect of MCP-96 compensators of varying thickness on the depth dose characteristics was investigated using a diamond detector which has a uniform energy response. A beam hardening effect was observed at 6 MV that resulted in a depth dose increase that remained below 2% at 20 cm depth. At 25 MV, in contrast, beam softening produced a dose decrease of up to 5% at the same depth. Second, dose was measured at depth using EDR2 film in perpendicular orientation to both 6 MV and 25 MV beams for different compensator thicknesses. A film dose underresponse of 1.1% was found for a 30 mm thick block in a 25 MV beam, which realized a transmission factor of 0.243. The effect induced by the compensators is higher than the experimental error but still within the accepted overall uncertainty of film dosimetry in clinical IMRT QA. With radiographic film as an affordable QA tool, the physical compensator remains a low threshold technique to deliver IMRT.     

Using the volumetric effect of a finite-sized detector for routine quality assurance of multileaf collimator leaf positioning

Intensity modulated radiation therapy (IMRT) is an advanced form of radiation therapy and promises to improve dose conformation while reducing the irradiation to the sensitive structures. The modality is, however, more complicated than conventional treatment and requires much more stringent quality assurance (QA) to ensure what has been planned can be achieved accurately. One of the main QA tasks is the assurance of positioning accuracy of multileaf collimator (MLC) leaves during IMRT delivery. Currently, the routine quality assurance of MLC in most clinics isbeing done using radiographic films with specially designed MLC leaf sequences. Besides being time consuming, the results of film measurements are difficult to quantify and interpret. In this work, we propose a new and effective technique for routine MLC leaf positioning QA. The technique utilizes the fact that, when a finite-sized detector is placed under a leaf, the relative output of the detector will depend on the relative fractional volume irradiated. A small error in leaf positioning would change the fractional volume irradiated and lead to a deviation of the relative output from the normal reading. For a given MLC and detector system, the relation between the relative output and the leaf displacement can be easily established through experimental measurements and used subsequently as a quantitative means for detecting possible leaf positional errors. The method was tested using a linear accelerator with an 80-leaf MLC. Three different locations, including two locations on central plane (X1 = X2 = 0) and one point on an off-central plane location (X1 = -7.5, X = 7.5), were studied. Our results indicated that the method could accurately detect a leaf positional change of approximately 0.1 mm. The method was also used to monitor the stability of MLC leaf positioning for five consecutive weeks. In this test, we intentionally introduced two positional errors in the testing MLC leaf sequences: -0.2 mm and 1.2 mm. The technique was found to be robust and could detect the positional inaccuracy in each week's test. The influence of other possible error sources, including the ion chamber placement, jaw settings, gantry and collimator angle read-outs, and the positioning errors of the adjacent leaves, on detection accuracy were also investigated. The principle of our method is independent of the types of the MLC and the detector and may have significant practical implications in facilitating routine MLC QA for IMRT delivery.     

计算分辨率对调强放疗计划验证Gamma通过率的影响

目的 分析调强放疗计划面剂量验证过程中剂量计算的分辨率对Gamma通过率结果的影响,找出针对不同评判标准对应恰当的计算分辨率数值.方法 选取25例调强放疗计划进行面剂量验证,对比分析采用2 mm计算分辨率时,使用3 mm/3％、2 mm/2％和1 mm/1％不同评判标准的Gamma通过率结果.采用0.5、1、3、4、5 mm不同的分辨率计算并输出面剂量分布,分别与使用Mapcheck测量到的该平面剂量分布进行Gamma通过率分析,对比分析采用不同计算分辨率得到的面剂量验证Gamma通过率结果.结果 25例计划的225个射野的面剂量验证Gamma通过率均值随着计算分辨率的增大而降低.采用3 mm/3％的评判标准时,计算分辨率为1 mm的面剂量验证Gamma通过率为98.3％±1.3％,与分辨率为0.5 mm的通过率98.3％±1.2％的数值很接近,其差异无统计学意义（P＞0.05）.计算分辨率≥3 mm的面剂量验证Gamma通过率相比于计算分辨率为0.5 mm的通过率均显著降低,其差异具有统计学意义（P＜0.05）.采用2 mm/2％的评判标准时,计算分辨率≥1 mm的面剂量验证Gamma通过率与计算分辨率为0.5 nn的通过率相比均有显著下降,其差异具有统计学意义（P＜0.05）.结论 面剂量分布的计算分辨率的增大会导致面剂量验证Gamma通过率的下降,应采用数值较低的分辨率计算面剂量分布,以消除计算分辨率对Gamma通过率结果的影响.建议采用3 mm/3％评判标准时剂量计算的分辨率选择1 mm,采用2 mm/2％的评判标准时剂量计算的分辨率选择0.5 mm,以保证验证结果的可靠性.     

A prototype quantitative film scanner for radiochromic film dosimetry

We have developed a high resolution, quantitative, two-dimensional optical film scanner for use with a commercial high sensitivity radiochromic film (RCF) for measuring single fraction external-beam radiotherapy dose distributions. The film scanner was designed to eliminate artifacts commonly observed in RCF dosimetry. The scanner employed a stationary light source and detector with a moving antireflective glass film platen attached to a high precision computerized X-Y translation stage. An ultrabright red light emitting diode (LED) with a peak output at 633 nm and full width at half maximum (FWHM) of 16 nm was selected as the scanner light source to match the RCF absorption peak. A dual detector system was created using two silicon photodiode detectors to simultaneously measure incident and transmitted light. The LED light output was focused to a submillimeter (FWHM 0.67 mm) spot size, which was determined from a scanning knife-edge technique for measuring Gaussian optical beams. Data acquisition was performed with a 16-bit A/D card in conjunction with commercial software. The linearity of the measured densities on the scanner was tested using a calibrated neutral-density step filter. Sensitometric curves and three IMRT field scans were acquired with a spatial resolution of 1 mm for both radiographic film and RCF. The results were compared with measurements taken with a commercial diode array under identical delivery conditions. The RCF was rotated by 90 deg and rescanned to study orientation effects. Comparison between the RCF and the diode array measurements using percent dose difference and distance-to-agreement criteria produced average passing rates of 99.0% using 3%/3 mm criteria and 96.7% using 2%/2 mm criteria. The same comparison between the radiographic film and diode array measurements resulted in average passing rates 96.6% and 91.6% for the above two criteria, respectively. No measurable light-scatter or interference scanner artifacts were observed. The RCF rotated by 90 deg showed no measurable orientation effect. A scan of a 15 x 15 cm2 area with 1 mm resolution required 22 min to acquire. The LED densitometer provides an accurate film dosimetry system with 1 mm or better resolution. The scanner eliminates the orientation dependence of RCF dosimetry that was previously reported with commercial flatbed scanners.